Gregoire Ramade - Jan 2, 2023 Form 4 Insider Report for VAPOTHERM INC (VAPO)

Role
SVP & Chief Commercial Officer
Signature
/s/Adrain Bryant, as Attorney In Fact
Stock symbol
VAPO
Transactions as of
Jan 2, 2023
Transactions value $
$14,364
Form type
4
Date filed
1/4/2023, 04:49 PM
Previous filing
Nov 17, 2022
Next filing
Jan 11, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VAPO Common Stock Award $14.4K +5.32K +6.4% $2.70 88.4K Jan 2, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VAPO Stock Option (right to buy) Award $0 +54.7K $0.00 54.7K Jan 2, 2023 Common Stock 54.7K $2.70 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock unit award granted under the Vapotherm, Inc. Amended and Restated 2018 Equity Incentive Plan (the "2018 Equity Plan") and the Vapotherm, Inc. Amended and Restated 2019 French Qualifying Sub Plan (the "French Sub Plan") in lieu of an annual increase in the reporting person's 2023 base salary. The restricted stock unit award will vest in full on December 31, 2023, subject to the reporting person's continued service as an employee or other service provider to the Issuer through the vesting date.
F2 Includes 58,553 shares that will be issued over time upon vesting and settlement of restricted stock unit awards.
F3 This option was granted under the 2018 Equity Plan and the French Sub Plan and will vest as to 25% of the underlying shares on January 2, 2024, and thereafter, as to the remaining 75% of underlying shares, in 36 monthly installments, subject to the reporting person's continued service as an employee or other service provider to the Issuer through the vesting dates.